xconomy.com 06 Feb, 2017
AB BioTechnologies will invest $10.5 million to build a new 23,000-square-foot facility. The new facility will include space to formulate, fill, freeze-dry, and package drugs for early-phase clinical research. The company will also relocate its existing warehouse and development laboratory to the new space. The new facility will be opened in November.